ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Candel Therapeutics Inc

Candel Therapeutics Inc (CADL)

6,665
-1,03
(-13,33%)
Geschlossen 18 Januar 10:00PM
6,93
0,265
( 3,98% )
Vor Marktöffnung: 11:50AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
6,93
Gebot
6,60
Fragen
6,94
Volumen
1.918
0,00 Tagesbereich 0,00
1,16 52-Wochen-Bereich 14,60
Marktkapitalisierung
Handelsende
6,665
Handelsbeginn
-
Letzte Trade
3
@
6.93
Letzter Handelszeitpunkt
12:02:18
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
4.115.440
Ausgegebene Aktien
32.475.537
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,70
Gewinn pro Aktie (EPS)
-1,17
Erlöse
-
Nettogewinn
-37,94M

Über Candel Therapeutics Inc

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Candel Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CADL. The last closing price for Candel Therapeutics was US$6,67. Over the last year, Candel Therapeutics shares have traded in a share price range of US$ 1,16 to US$ 14,60.

Candel Therapeutics currently has 32.475.537 shares in issue. The market capitalisation of Candel Therapeutics is US$216,45 million. Candel Therapeutics has a price to earnings ratio (PE ratio) of -5.70.

CADL Neueste Nachrichten

Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025

On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC), expected in Q1...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.88-11.26760563387.818.086.6521138227.63662599CS
4-1.58-18.56639247948.519.86836.6517041978.33432251CS
121.527.62430939235.4314.63.78541154407.8172565CS
260.9215.30782029956.0114.63.78519713117.70763382CS
525.66445.6692913391.2714.61.1624907757.13100111CS
1560.6810.886.2514.60.668918066.72423146CS
260-1.07-13.375814.780.667795336.76007535CS

CADL - Frequently Asked Questions (FAQ)

What is the current Candel Therapeutics share price?
The current share price of Candel Therapeutics is US$ 6,93
How many Candel Therapeutics shares are in issue?
Candel Therapeutics has 32.475.537 shares in issue
What is the market cap of Candel Therapeutics?
The market capitalisation of Candel Therapeutics is USD 216,45M
What is the 1 year trading range for Candel Therapeutics share price?
Candel Therapeutics has traded in the range of US$ 1,16 to US$ 14,60 during the past year
What is the PE ratio of Candel Therapeutics?
The price to earnings ratio of Candel Therapeutics is -5,7
What is the reporting currency for Candel Therapeutics?
Candel Therapeutics reports financial results in USD
What is the latest annual profit for Candel Therapeutics?
The latest annual profit of Candel Therapeutics is USD -37,94M
What is the registered address of Candel Therapeutics?
The registered address for Candel Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Candel Therapeutics website address?
The website address for Candel Therapeutics is www.candeltx.com
Which industry sector does Candel Therapeutics operate in?
Candel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 0,8561
(84,31%)
17,64M
BBGIBeasley Broadcast Group Inc
US$ 13,17
(59,25%)
19
QETAQuetta Acquisition Corporation
US$ 16,82
(59,13%)
88
IROHIron Horse Acquisition Corporation
US$ 16,01
(54,99%)
4
DWTXDogwood Therapeutics Inc
US$ 2,68
(43,32%)
5,15M
GOEVCanoo Inc
US$ 0,3525
(-73,89%)
1,34M
ELVNEnliven Therapeutics Inc
US$ 10,11
(-52,91%)
20
CUBLionheart Holdings
US$ 5,11
(-49,51%)
1
ALRSAlerus Financial Corporation
US$ 12,01
(-38,79%)
13
MDXGMiMedx Group Inc
US$ 6,01
(-34,10%)
9
CRKNCrown Electrokinetics Corporation
US$ 0,16
(28,00%)
57,7M
ASSTAsset Entities Inc
US$ 0,8561
(84,31%)
17,64M
CGBSCrown LNG Holdings Ltd
US$ 0,9079
(21,41%)
10,37M
RIMEAlgorhythm Holdings Inc
US$ 0,0392
(-5,77%)
6,64M
DWTXDogwood Therapeutics Inc
US$ 2,68
(43,32%)
5,15M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock